Literature DB >> 23614810

Cytokine patterns differ seasonally between women with and without uterine leiomyomata.

Ganesa Wegienka1, Donna Day Baird, Tracy Cooper, Kimberley J Woodcroft, Suzanne Havstad.   

Abstract

PROBLEM: Uterine leiomyomata are the most common reproductive tumor in women, and their cause is not known. METHODS OF STUDY: Plasma samples from 155 women (74 with and 81 without ultrasound-confirmed leiomyoma) from a new study of leiomyoma risk factors in the Detroit, Michigan area, were examined for any cross-sectional associations between commonly examined cytokines and leiomyoma presence.
RESULTS: Associations varied by season of sample collection defined a priori as winter (December-February) and non-winter seasons. In the winter months, interleukin (IL)13 and IL17 were positively and IP10 was inversely associated with having a leiomyoma. In the non-winter samples, VEGF, G-CSF, and IP10 were positively associated and Monocyte chemotactic protein-1, IL13, and IL17 were inversely associated with having a leiomyoma. Associations were not changed by adjustment for age or BMI.
CONCLUSIONS: These data suggest that new insight into leiomyoma formation may be acquired through investigation of the immune system.
© 2013 John Wiley & Sons Ltd.

Entities:  

Keywords:  chemokines; cytokines; growth factors; inflammation; leiomyoma

Mesh:

Substances:

Year:  2013        PMID: 23614810      PMCID: PMC3745526          DOI: 10.1111/aji.12127

Source DB:  PubMed          Journal:  Am J Reprod Immunol        ISSN: 1046-7408            Impact factor:   3.886


  38 in total

1.  Interleukin (IL)-12 receptor beta1 codon 378 G homozygote and allele, but not IL-1 (beta-511 promoter, 3953 exon 5, receptor antagonist), IL-2 114, IL-4-590 intron 3, IL-8 3'-UTR 2767, and IL-18 105, are associated with higher susceptibility to leiomyoma.

Authors:  Yao-Yuan Hsieh; Chi-Chen Chang; Chang-Hai Tsai; Cheng-Chieh Lin; Fuu-Jen Tsai
Journal:  Fertil Steril       Date:  2007-01-12       Impact factor: 7.329

Review 2.  VEGF: an update on biological and therapeutic aspects.

Authors:  N Ferrara
Journal:  Curr Opin Biotechnol       Date:  2000-12       Impact factor: 9.740

3.  Leiomyoma-related hospitalization and surgery: prevalence and predicted growth based on population trends.

Authors:  Mary Ellen Wechter; Elizabeth A Stewart; Evan R Myers; Rosanne M Kho; Jennifer M Wu
Journal:  Am J Obstet Gynecol       Date:  2011-07-20       Impact factor: 8.661

4.  Are uterine leiomyoma a consequence of a chronically inflammatory immune system?

Authors:  Ganesa Wegienka
Journal:  Med Hypotheses       Date:  2012-05-18       Impact factor: 1.538

5.  Influence of body size and body fat distribution on risk of uterine leiomyomata in U.S. black women.

Authors:  Lauren A Wise; Julie R Palmer; Donna Spiegelman; Bernard L Harlow; Elizabeth A Stewart; Lucile L Adams-Campbell; Lynn Rosenberg
Journal:  Epidemiology       Date:  2005-05       Impact factor: 4.822

6.  Differential distribution of allelic variants in cytokine genes among African Americans and White Americans.

Authors:  Roberta B Ness; Catherine L Haggerty; Gail Harger; Robert Ferrell
Journal:  Am J Epidemiol       Date:  2004-12-01       Impact factor: 4.897

Review 7.  Leiomyoma-related bleeding: a classic hypothesis updated for the molecular era.

Authors:  E A Stewart; R A Nowak
Journal:  Hum Reprod Update       Date:  1996 Jul-Aug       Impact factor: 15.610

8.  Tumor necrosis factor-alpha-308 promoter and p53 codon 72 gene polymorphisms in women with leiomyomas.

Authors:  Yao-Yuan Hsieh; Chi-Chen Chang; Fuu-Jen Tsai; Cheng-Chieh Lin; Lian-Shun Yeh; Chang-Hai Tsai
Journal:  Fertil Steril       Date:  2004-10       Impact factor: 7.329

9.  Reproductive factors and risk of uterine fibroids.

Authors:  F Parazzini; E Negri; C La Vecchia; L Chatenoud; E Ricci; P Guarnerio
Journal:  Epidemiology       Date:  1996-07       Impact factor: 4.822

Review 10.  Interleukin 13 and its role in gut defence and inflammation.

Authors:  Peter Mannon; Walter Reinisch
Journal:  Gut       Date:  2012-09-01       Impact factor: 23.059

View more
  6 in total

Review 1.  Epidemiological and genetic clues for molecular mechanisms involved in uterine leiomyoma development and growth.

Authors:  Arno E Commandeur; Aaron K Styer; Jose M Teixeira
Journal:  Hum Reprod Update       Date:  2015-07-03       Impact factor: 15.610

Review 2.  The Role of Tumor Necrosis Factor α in the Biology of Uterine Fibroids and the Related Symptoms.

Authors:  Michał Ciebiera; Marta Włodarczyk; Magdalena Zgliczyńska; Krzysztof Łukaszuk; Błażej Męczekalski; Christopher Kobierzycki; Tomasz Łoziński; Grzegorz Jakiel
Journal:  Int J Mol Sci       Date:  2018-12-04       Impact factor: 5.923

3.  Meta-Study of the Clinical Effect of Conservative Treatment in Uterine Fibroids.

Authors:  Hanxiao Zhu; Xiaoli Lai; Jinhong Wu; Chenan Guan; Junhui Yu
Journal:  J Oncol       Date:  2022-07-31       Impact factor: 4.501

Review 4.  Abnormal uterine bleeding.

Authors:  Lucy Whitaker; Hilary O D Critchley
Journal:  Best Pract Res Clin Obstet Gynaecol       Date:  2015-11-25       Impact factor: 5.237

5.  A novel method to identify differential pathways in uterine leiomyomata based on network strategy.

Authors:  Hui-Ling Wang; Jing Liu; Zhao-Min Qin
Journal:  Oncol Lett       Date:  2017-09-14       Impact factor: 2.967

Review 6.  Biomarkers in abnormal uterine bleeding†.

Authors:  Rohan Chodankar; Hilary O D Critchley
Journal:  Biol Reprod       Date:  2019-12-24       Impact factor: 4.285

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.